Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Scandinavian ChemoTech

3,70 SEK

-1,07 %

Mindre end 1K følgere

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-1,07 %
-31,48 %
+4,82 %
+78,74 %
+106,70 %
+135,67 %
-30,99 %
-65,15 %
-90,18 %

Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.

Læs mere
Markedsværdi
94,18 mio. SEK
Aktieomsætning
216,21 t SEK
Omsætning
6,57 mio.
EBIT %
-194,82 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
3.3
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelsefor 10 timer siden

ChemoTech's Animal Care Announces First U.S. Order from Leading Equine Clinic in Kentucky

Scandinavian ChemoTech
Pressemeddelelse5.11.2025, 10.14

Redeye: Scandinavian ChemoTech (Q3 Review) - Strong momentum in revenue from treatment kits

Scandinavian ChemoTech
Selskabsmeddelelse4.11.2025, 07.03

Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025

Scandinavian ChemoTech

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse17.10.2025, 06.40

Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide

Scandinavian ChemoTech
Selskabsmeddelelse1.10.2025, 12.43

ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown

Scandinavian ChemoTech
Pressemeddelelse26.9.2025, 13.35

ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion

Scandinavian ChemoTech
Pressemeddelelse19.9.2025, 13.21

Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom

Scandinavian ChemoTech
Selskabsmeddelelse12.9.2025, 05.23

ChemoTech's Animal Care Expands University Partnerships with SLU Equine Hospital in Ultuna

Scandinavian ChemoTech
Pressemeddelelse25.8.2025, 13.15

Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership

Scandinavian ChemoTech
Selskabsmeddelelse20.8.2025, 09.50

Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide

Scandinavian ChemoTech
Pressemeddelelse14.8.2025, 14.21

Redeye: Scandinavian ChemoTech - Growth tailwinds

Scandinavian ChemoTech
Selskabsmeddelelse12.8.2025, 06.05

Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025

Scandinavian ChemoTech
Pressemeddelelse29.7.2025, 12.31

Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth

Scandinavian ChemoTech
Selskabsmeddelelse27.7.2025, 10.15

Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK

Scandinavian ChemoTech
Pressemeddelelse25.7.2025, 06.45

(RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation

Scandinavian ChemoTech
Selskabsmeddelelse24.7.2025, 14.25

Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation

Scandinavian ChemoTech
Pressemeddelelse2.7.2025, 06.45

(RETRANS) ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025

Scandinavian ChemoTech
Selskabsmeddelelse1.7.2025, 14.45

ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025

Scandinavian ChemoTech
Pressemeddelelse24.6.2025, 12.20

ChemoTech: Full Management and Board Subscribes to the Warrant Program Adopted by the AGM

Scandinavian ChemoTech
Pressemeddelelse7.5.2025, 10.11

Redeye: Scandinavian ChemoTech - Momentum continues

Scandinavian ChemoTech
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.